Exciting new medication for ADHD!
- J Mo
- Jan 24
- 1 min read
Updated: 5 days ago

There is a new non-stimulant drug approved by the FDA to treat ADHD. It's called Centanafadine.
It's not yet approved, but via the pharm company's link: PRINCETON, N.J. & TOKYO, January 27, 2026--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for centanafadine, an investigational, once-daily extended release capsule and the first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. The Prescription Drug User Fee Act (PDUFA) target action date is set for July 24, 2026.
Here is the link if you want to read it straight from the source: https://finance.yahoo.com/news/otsuka-announces-fda-acceptance-priority-130200847.html
Here's the summary of the study: https://www.psychiatrist.com/news/otsuka-seeks-fda-approval-for-new-adhd-drug/
tl;dr So basically, end of July.



Comments